Skip to main content

Peer Review reports

From: The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure

Original Submission
18 Nov 2020 Submitted Original manuscript
2 Jan 2021 Reviewed Reviewer Report
21 Feb 2021 Reviewed Reviewer Report - Rupert W. Major
26 Mar 2021 Author responded Author comments - Daniel Murphy
Resubmission - Version 2
26 Mar 2021 Submitted Manuscript version 2
31 Mar 2021 Reviewed Reviewer Report - Rupert W. Major
21 May 2021 Author responded Author comments - Daniel Murphy
Resubmission - Version 3
21 May 2021 Submitted Manuscript version 3
7 Jun 2021 Author responded Author comments - Daniel Murphy
Resubmission - Version 4
7 Jun 2021 Submitted Manuscript version 4
Publishing
10 Jun 2021 Editorially accepted
6 Jul 2021 Article published 10.1186/s12882-021-02439-2

You can find further information about peer review here.

Back to article page